Jupiros Gold 10 Capsule is a combination medication containing Aspirin (75 mg), Rosuvastatin (10 mg), and Clopidogrel (75 mg), indicated for the prevention of cardiovascular events in patients at high risk of atherosclerotic disease. Aspirin acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase-1 (COX-1), thereby reducing thromboxane A2 production and platelet aggregation. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP receptor on platelet cell membranes, preventing platelet activation and aggregation. Rosuvastatin, a potent HMG-CoA reductase inhibitor, lowers low-density lipoprotein cholesterol (LDL-C) levels and exerts pleiotropic effects that stabilize atherosclerotic plaques and reduce inflammation. The combined use of these agents provides a synergistic effect in reducing the risk of myocardial infarction, stroke, and other thrombotic complications in patients with established cardiovascular disease or those with multiple risk factors. Jupiros Gold 10 Capsule should be administered under medical supervision, with regular monitoring of lipid profiles, liver function, and bleeding parameters. Caution is advised in patients with bleeding disorders, hepatic impairment, or hypersensitivity to any component. This combination therapy is an integral part of secondary prevention strategies in cardiovascular medicine.